Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05412992 · ClinicalTrials.gov registry record · Phase 2
Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty
A Phase 2 study, sponsored by Teikoku Pharma USA.
- Terminated
- Registry status
- Phase 2
- Development phase
- 179
- Enrollment target
NCT05412992 is a Phase 2 study that was terminated before completion, run by Teikoku Pharma USA. The registered enrollment target is 179 participants.
The verdict
NCT05412992, a Phase 2 study, was terminated before completion, sponsored by Teikoku Pharma USA.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 179 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the analgesic efficacy of DMTS, compared with placebo, in subjects following abdominoplasty.
Interventions
- DRUG Placebo Patch
- DRUG DMTS Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2022-07-07 |
| Est. Completion | 2023-04-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05412992
The ClinicalTrials.gov registry entry for NCT05412992 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 179 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teikoku Pharma USA, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Patch is the first listed.
NCT05412992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05412992 about?
NCT05412992 is a clinical study titled "Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty". The primary objective of this study is to evaluate the analgesic efficacy of DMTS, compared with placebo, in subjects following abdominoplasty.
What is the current status of trial NCT05412992?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 179 participants. The study started on 2022-07-07. Estimated completion is 2023-04-19.
What interventions are being tested in trial NCT05412992?
The interventions under investigation include: Placebo Patch (DRUG), DMTS Patch (DRUG).
Who is sponsoring clinical trial NCT05412992?
This trial is sponsored by Teikoku Pharma USA, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.